1. Home
  2. PRCH vs ERAS Comparison

PRCH vs ERAS Comparison

Compare PRCH & ERAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Porch Group Inc.

PRCH

Porch Group Inc.

HOLD

Current Price

$8.20

Market Cap

880.9M

Sector

Technology

ML Signal

HOLD

Logo Erasca Inc.

ERAS

Erasca Inc.

HOLD

Current Price

$13.57

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRCH
ERAS
Founded
2012
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
880.9M
1.0B
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
PRCH
ERAS
Price
$8.20
$13.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
9
Target Price
$17.11
$5.78
AVG Volume (30 Days)
2.0M
3.7M
Earning Date
05-13-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
90.91
16.87
EPS
N/A
N/A
Revenue
$482,414,000.00
N/A
Revenue This Year
$2.37
N/A
Revenue Next Year
$16.96
N/A
P/E Ratio
N/A
N/A
Revenue Growth
10.18
N/A
52 Week Low
$4.65
$1.01
52 Week High
$19.44
$14.17

Technical Indicators

Market Signals
Indicator
PRCH
ERAS
Relative Strength Index (RSI) 51.69 76.07
Support Level $6.36 $1.27
Resistance Level $9.89 N/A
Average True Range (ATR) 0.64 0.73
MACD 0.07 -0.07
Stochastic Oscillator 46.37 78.30

Price Performance

Historical Comparison
PRCH
ERAS

About PRCH Porch Group Inc.

Porch Group Inc is a vertical software company reinventing the home services and insurance industries. It has two reportable segments: The vertical Software segment provides software and services to home services companies. The Vertical Software segment software and services provide inspection, mortgage, and title companies on a subscription and transactional basis, several key businesses, including inspection software and services, title insurance software, mortgage software, moving services, mover and homeowner marketing, and measurement software for roofers. The insurance segment provides consumers with insurance and warranty products to protect their homes, earning revenue through premiums collected on policies, policy fees, and commissions. Majority revenue is from Insurance segment.

About ERAS Erasca Inc.

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.

Share on Social Networks: